価格表

在庫・価格 : 2024年05月02日 04時42分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Adeno-Associated Virus, VP1+VP2, Mouse-Mono(A69) <Anti-AAV>
データシート
61057 POGプロジェン バイオテクニック
PROGEN Biotechnik GmbH
50 μg ¥122,000
(未発注)
追加

在庫・価格 : 2024年05月02日 04時42分 現在

Anti-Adeno-Associated Virus, VP1+VP2, Mouse-Mono(A69) <Anti-AAV>

  • 商品コード:61057
  • メーカー:POG
  • 包装:50μg
  • 価格: ¥122,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Wobus CE et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 2000 Oct;74(19):9281-9
Wobus CE et al
2000/01/01
PubMed
2 Wistuba A et al. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 1997 Feb;71(2):1341-52
Wistuba A et al
1997/01/01
PubMed
3 Wistuba A et al. Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 1995 Sep;69(9):5311-9
Wistuba A et al
1995/01/01
Applications (Species): WB (AAV2), IP (AAV2) PubMed
4 Wistuba, A. et al. Subcellular Compartmentalization of Adeno-Associated Virus Type 2 Assembly. J. Virol. 71, 1341-1352 (1997).

species: AAV2, application: WB, IP, ICC-IF PubMed
5 Wistuba, A., Weger, S., Kern, A., Rgen, J. and Kleinschmidt, A. Intermediates of Adeno-Associated Virus Type 2 Assembly: Identification of Soluble Complexes Containing Rep and Cap Proteins. J. Virol. 69, 5311-5319 (1995).

species: AAV2, application: WB, IP PubMed
6 Hamann MV et al. Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors. PLoS One 2021;16(12):e0261269
Hamann MV et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Wobus CE et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 2000 Oct;74(19):9281-9
    Wobus CE et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wistuba A et al. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 1997 Feb;71(2):1341-52
    Wistuba A et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wistuba A et al. Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 1995 Sep;69(9):5311-9
    Wistuba A et al
    1995/01/01
  • 備考:
    Applications (Species): WB (AAV2), IP (AAV2)
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Wistuba, A. et al. Subcellular Compartmentalization of Adeno-Associated Virus Type 2 Assembly. J. Virol. 71, 1341-1352 (1997).

  • 備考:
    species: AAV2, application: WB, IP, ICC-IF
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Wistuba, A., Weger, S., Kern, A., Rgen, J. and Kleinschmidt, A. Intermediates of Adeno-Associated Virus Type 2 Assembly: Identification of Soluble Complexes Containing Rep and Cap Proteins. J. Virol. 69, 5311-5319 (1995).

  • 備考:
    species: AAV2, application: WB, IP
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Hamann MV et al. Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors. PLoS One 2021;16(12):e0261269
    Hamann MV et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed